Dynavax Technologies Corporation's flagship product, Heplisav-B, continues to increase market share consistently in a growing ...

GRAND JUNCTION, Colo. (KJCT) - Community members will have an opportunity to get a vaccine for a low cost. The Center for ...

The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

Private insurance companies in the U.S. aren’t required to cover the cost of the mpox vaccine Jynneos, which costs $270 a ...

By Keith Roach, M.D. TITLE: 63-year-old debates getting shingles and chicken pox vaccines---DEAR DR. ROACH: A few months ago, yo ...

Nova Scotia’s Progressive Conservatives promised on Tuesday to introduce a universal shingles vaccine program for people 65 ...

The epidemic in Africa continues to grow, prompting fears of another outbreak in the U.S. But the vaccine is no longer free, ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected absent ...

GSK plc GSK reported third-quarter 2024 core earnings of $1.27 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.16. Core earnings declined 1% year over year on a ...

Sales of GSK's key vaccine Arexvy slumped 72% at constant currency to 188 million pounds after U.S. health officials in June restricted the shot to a smaller age range and more at-risk patients.

The drugmaker saw weaker-than-expected demand for its respiratory syncytial virus (RSV) and shingles vaccines over the period, and GSK now expects total sales to fall this year by a low-single ...